Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

New direction in NOS research: Potential application in gene therapy of impotence

Aug. 5, 1997

Lilly creates new business unit dedicated to women's health

Aug. 5, 1997

Tonalin CLA reduces body fat

Aug. 5, 1997

Rezulin receives FDA marketing clearance for type 2 diabetes

Aug. 5, 1997

Sibutramine: New hope for obese patients

Aug. 5, 1997

Bioniche to manufacture Orphan Medical's Intrachol

Aug. 5, 1997

U.S. patent issues for bone substitute technology

Aug. 5, 1997

Insulin mediator isolated from beef liver

Aug. 5, 1997

Alteon's pimagedine progresses to phase III

Aug. 4, 1997

Crinone approved in U.S. for additional indication

Aug. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...